131 related articles for article (PubMed ID: 35872035)
1. Multi-institutional Care in Clinical Stage II and III Esophageal Cancer.
Rhodin KE; Raman V; Jensen CW; Kang L; Nussbaum DP; Tong BC; Blazer DG; D'Amico TA
Ann Thorac Surg; 2023 Feb; 115(2):370-377. PubMed ID: 35872035
[TBL] [Abstract][Full Text] [Related]
2. Patterns and Impact of Fragmented Care in Stage II and III Gastric Cancer.
Rhodin KE; Raman V; Eckhoff A; Liu A; Creasy J; Nussbaum DP; Blazer DG
Ann Surg Oncol; 2022 Sep; 29(9):5422-5431. PubMed ID: 35723791
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Diabetes on Pathologic Complete Response Among Patients With Esophageal Cancer.
Alvarado CE; Kapcio KC; Lada MJ; Linden PA; Towe CW; Worrell SG
Semin Thorac Cardiovasc Surg; 2023; 35(2):429-436. PubMed ID: 35248723
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
[TBL] [Abstract][Full Text] [Related]
6. Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
Chambers LM; Jia X; Rose PG; AlHilli M
Gynecol Oncol; 2021 Feb; 160(2):405-412. PubMed ID: 33221023
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.
Buckstein M; Rhome R; Ru M; Moshier E
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29309563
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study.
Semenkovich TR; Subramanian M; Yan Y; Hofstetter WL; Correa AM; Cassivi SD; Inra ML; Stiles BM; Altorki NK; Chang AC; Brescia AA; Darling GE; Allison F; Broderick SR; Etchill EW; Fernandez FG; Chihara RK; Litle VR; Muñoz-Largacha JA; Kozower BD; Puri V; Meyers BF
Ann Thorac Surg; 2019 Sep; 108(3):828-836. PubMed ID: 31229485
[TBL] [Abstract][Full Text] [Related]
10. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
[TBL] [Abstract][Full Text] [Related]
11. Effects of preoperative radiotherapy on survival of patients with stage II and III esophageal squamous cell carcinoma: A population-based study.
Dong J; Shen W; Du X; Zhu S
Medicine (Baltimore); 2021 Oct; 100(41):e27345. PubMed ID: 34731106
[TBL] [Abstract][Full Text] [Related]
12. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
13. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
14. Radiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer.
Miller JA; Groman A; Yendamuri S; Hennon M
J Surg Res; 2019 Apr; 236():259-265. PubMed ID: 30694764
[TBL] [Abstract][Full Text] [Related]
15. Association of time to resection with survival in patients with colon cancer.
Sakowitz S; Bakhtiyar SS; Verma A; Ebrahimian S; Vadlakonda A; Mabeza RM; Lee H; Benharash P
Surg Endosc; 2024 Feb; 38(2):614-623. PubMed ID: 38012438
[TBL] [Abstract][Full Text] [Related]
16. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma.
Raman V; Jawitz OK; Voigt SL; Rhodin KE; Kim AW; Tong BC; D'Amico TA; Harpole DH
Ann Thorac Surg; 2020 Dec; 110(6):1832-1839. PubMed ID: 32622794
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
20. Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
Oncologist; 2022 Sep; 27(9):740-750. PubMed ID: 35648074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]